Peng S, Zhan Y, Zhang D, Ren L, Chen A, Chen Z
Proc Natl Acad Sci U S A. 2023; 120(6):e2216230120.
PMID: 36724251
PMC: 9963752.
DOI: 10.1073/pnas.2216230120.
Ayoub M, Vijayan R
Pharmaceuticals (Basel). 2021; 14(3).
PMID: 33799973
PMC: 7998264.
DOI: 10.3390/ph14030225.
Silva Monteiro de Paula G, Wilieman M, Silva K, Baptista L, Boudina S, Souza L
J Mol Endocrinol. 2019; 63(1):93-102.
PMID: 31067509
PMC: 9931200.
DOI: 10.1530/JME-19-0032.
Ramos-Alvarez I, Lee L, Mantey S, Jensen R
J Pharmacol Exp Ther. 2019; 369(3):454-465.
PMID: 30971479
PMC: 6519687.
DOI: 10.1124/jpet.118.255141.
Xiao C, Pinol R, Carlin J, Li C, Deng C, Gavrilova O
Mol Metab. 2017; 6(11):1540-1550.
PMID: 29107299
PMC: 5681273.
DOI: 10.1016/j.molmet.2017.08.013.
Mechanism of bombesin-induced tonic contraction of the porcine lower esophageal sphincter.
Tsai C, Chang L, Lin K, Tey S, Su Y, Liu C
Sci Rep. 2015; 5:15879.
PMID: 26522854
PMC: 4629149.
DOI: 10.1038/srep15879.
Bombesin receptor subtype 3 as a potential target for obesity and diabetes.
Gonzalez N, Moreno P, Jensen R
Expert Opin Ther Targets. 2015; 19(9):1153-70.
PMID: 26066663
PMC: 5417335.
DOI: 10.1517/14728222.2015.1056154.
Insights into bombesin receptors and ligands: Highlighting recent advances.
Ramos-Alvarez I, Moreno P, Mantey S, Nakamura T, Nuche-Berenguer B, Moody T
Peptides. 2015; 72:128-44.
PMID: 25976083
PMC: 4641779.
DOI: 10.1016/j.peptides.2015.04.026.
Targeting GRPR in urological cancers--from basic research to clinical application.
Mansi R, Fleischmann A, Macke H, Reubi J
Nat Rev Urol. 2013; 10(4):235-44.
PMID: 23507930
DOI: 10.1038/nrurol.2013.42.
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Rick F, Buchholz S, Schally A, Szalontay L, Krishan A, Datz C
Cell Cycle. 2012; 11(13):2518-25.
PMID: 22751419
PMC: 3404878.
DOI: 10.4161/cc.20900.
A selective human bombesin receptor subtype-3 peptide agonist mediates CREB phosphorylation and transactivation.
Qin X, Qu X, Coy D, Weber H
J Mol Neurosci. 2011; 46(1):88-99.
PMID: 22127929
DOI: 10.1007/s12031-011-9675-3.
Activation of bombesin receptor subtype-3 influences activity of orexin neurons by both direct and indirect pathways.
Furutani N, Hondo M, Tsujino N, Sakurai T
J Mol Neurosci. 2010; 42(1):106-11.
PMID: 20467915
DOI: 10.1007/s12031-010-9382-5.
International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.
Jensen R, Battey J, Spindel E, Benya R
Pharmacol Rev. 2007; 60(1):1-42.
PMID: 18055507
PMC: 2517428.
DOI: 10.1124/pr.107.07108.
Factors contributing to obesity in bombesin receptor subtype-3-deficient mice.
Ladenheim E, Hamilton N, Behles R, Bi S, Hampton L, Battey J
Endocrinology. 2007; 149(3):971-8.
PMID: 18039774
PMC: 2275361.
DOI: 10.1210/en.2007-1319.
Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.
ter Beek W, Muller E, van Hogezand R, Biemond I, Lamers C
J Clin Pathol. 2004; 57(10):1047-51.
PMID: 15452158
PMC: 1770439.
DOI: 10.1136/jcp.2003.014993.
Immunomodulatory functions of the diffuse neuroendocrine system: implications for bronchopulmonary dysplasia.
Sunday M, Shan L, Subramaniam M
Endocr Pathol. 2004; 15(2):91-106.
PMID: 15299196
DOI: 10.1385/ep:15:2:091.
Molecular cloning and characterization of avian bombesin-like peptide receptors: new tools for investigating molecular basis for ligand selectivity.
Iwabuchi M, Ui-Tei K, Yamada K, Matsuda Y, Sakai Y, Tanaka K
Br J Pharmacol. 2003; 139(3):555-66.
PMID: 12788815
PMC: 1573881.
DOI: 10.1038/sj.bjp.0705282.
Identification and functional characterization of hemorphins VV-H-7 and LVV-H-7 as low-affinity agonists for the orphan bombesin receptor subtype 3.
Lammerich H, Busmann A, Kutzleb C, Wendland M, Seiler P, Berger C
Br J Pharmacol. 2003; 138(8):1431-40.
PMID: 12721098
PMC: 1573796.
DOI: 10.1038/sj.bjp.0705177.
A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells.
Weber H, Walters J, Leyton J, Casibang M, Purdom S, Jensen R
Eur J Pharmacol. 2001; 412(1):13-20.
PMID: 11166731
PMC: 8855643.
DOI: 10.1016/s0014-2999(00)00941-9.
Functional properties of two bombesin-like peptide receptors revealed by the analysis of mice lacking neuromedin B receptor.
Ohki-Hamazaki H, Sakai Y, Kamata K, Ogura H, Okuyama S, Watase K
J Neurosci. 1999; 19(3):948-54.
PMID: 9920658
PMC: 6782144.